OR
DXCM icon

Olympiad Research’s DexCom DXCM Stock Holding History

Olympiad Research’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,571
Closed -$312K – 213
2025
Q1 		$312K Buy
+4,571
New +$373K 0.36% 69
2024
Q3 		– Sell
-4,298
Closed -$487K – 372
2024
Q2 		$487K Buy
4,298
+1,830
+74% +$231K 0.36% 58
2024
Q1 		$342K Buy
2,468
+168
+7% +$21.1K 0.22% 164
2023
Q4 		$285K Sell
2,300
-155
-6% -$15.8K 0.22% 176
2023
Q3 		$229K Buy
+2,455
New +$277K 0.22% 218
2023
Q2 		– Sell
-3,718
Closed -$432K – 275
2023
Q1 		$432K Buy
+3,718
New +$416K 0.5% 44

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Olympiad Research's DXCM Position: Q2 2025 in Review

Olympiad Research sold out of DexCom (DXCM) in Q2 2025, closing a stake of 4,571 shares — an estimated $312K sold.

Olympiad Research first reported a position in DXCM in Q1 2023 and held it in 6 quarters. The position peaked at $487K in Q2 2024. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Olympiad Research reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Olympiad Research sold 4,571 DexCom shares in Q2 2025, an estimated $312K.
  • Olympiad Research first reported a position in DexCom in Q1 2023 and held it in 6 quarters.
  • Olympiad Research's DexCom position peaked at $487K in Q2 2024.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Olympiad Research's 13F filing for Q2 2025, filed 8 Aug 2025.